# Protecting Preterm Infants From Respiratory Tract Infections and Wheeze by Using Bacterial Lysates.

> **NCT05063149** · PHASE3 · RECRUITING · sponsor: **Franciscus Gasthuis** · enrollment: 500 (estimated)

## Conditions studied

- Wheezing
- LRTI
- Premature

## Interventions

- **DRUG:** Broncho-Vaxom
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT05063149
- **Lead sponsor:** Franciscus Gasthuis
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-01-18
- **Primary completion:** 2025-12
- **Final completion:** 2026-12
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2024-08-22

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05063149

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05063149, "Protecting Preterm Infants From Respiratory Tract Infections and Wheeze by Using Bacterial Lysates.". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05063149. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*